Institution
Thermo Fisher Scientific (United States)
Recent research
- BiologyOpen access
Abstract Fish populations are notoriously difficult to monitor because their aquatic habitats limit observation. While physical or chemical tagging (e.g., adipose fin removal or Alizarin Red S staining of bones) can reduce growth or survival or requires sacrifice, genetic tools o...
- Climate & Environment
Abstract Identifying key toxicants that drive biological effects in complex samples remains a major challenge for environmental analytical chemistry. Here, we developed an AhR-oriented machine-learning model, EIMSFrag-AhR, to predict AhR agonistic activity directly from GC-EI-MS...
- BiologyOpen access
TWIK-related acid-sensitive K+ channel 2 (TASK-2) is a pH sensing two-pore K + (K2P) channel that regulates respiration in brainstem neurons and systemic pH homeostasis in kidney. Despite its physiological importance and implication in disease, the molecular basis for intracellul...
- BiologyOpen access
RATIONALE: Untargeted lipidomics is commonly performed at analytical flow rates, which consume more solvent and may require higher on-column sample loads when sensitivity is limited by analyte abundance. Nano flow separations use lower flow rates and sample loads, reducing solven...
- Climate & EnvironmentOpen access
The degradation of paint is thought to be a major pathway of microplastics to the environment. However, pollution from paint microplastics is challenging to assess due to a lack of paint-specific spectral libraries and visual keys to aid in the differentiation of paint microplast...
- Health & MedicineOpen access
Abstract Objectives Serum M-protein analysis is central to the assessment of monoclonal gammopathies. Quantitation and isotyping are commonly performed by SPE or CZE and IFE or IT, respectively. While these assays are widely used, they are characterized by limited sensitivity and...
- Health & MedicineOpen access
INTRODUCTION: This study evaluated the potential public health impact of receiving Pfizer-BioNTech COVID-19 vaccine, LP.8.1, 2025-2026 formula, in the US pediatric population aged 5-17 years at high risk of severe outcomes from COVID-19. RESEARCH DESIGN AND METHODS: A previously...